000 01723 a2200481 4500
005 20250517002208.0
264 0 _c20150714
008 201507s 0 0 eng d
022 _a1573-7217
024 7 _a10.1007/s10549-014-3144-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTwelves, Chris
245 0 0 _aEfficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cDec 2014
300 _a553-61 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnthracyclines
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aBridged-Ring Compounds
_xadministration & dosage
650 0 4 _aCapecitabine
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aFurans
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKetones
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aReceptor, ErbB-2
_xgenetics
650 0 4 _aTaxoids
_xadministration & dosage
700 1 _aCortes, Javier
700 1 _aVahdat, Linda
700 1 _aOlivo, Martin
700 1 _aHe, Yi
700 1 _aKaufman, Peter A
700 1 _aAwada, Ahmad
773 0 _tBreast cancer research and treatment
_gvol. 148
_gno. 3
_gp. 553-61
856 4 0 _uhttps://doi.org/10.1007/s10549-014-3144-y
_zAvailable from publisher's website
999 _c24339495
_d24339495